Related Experiment Video

Updated: Jun 28, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives

Ilaria Salvato1,2,3, Antonio Marchini2,4

  • 1NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.

Cancers
|April 13, 2024
PubMed

Insights

Glioblastoma (GBM) remains deadly despite treatments. This review explores immunotherapy strategies, including checkpoint inhibitors and vaccines, to improve survival for this aggressive brain cancer.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Therapy

Background:

  • Grade 4 Glioblastoma (GBM) has a poor prognosis, with median survival under 2 years despite current treatments.
  • Immunotherapy offers promise for GBM, but clinical success has been limited.
  • Understanding GBM's unique biology is key to developing effective treatments.

Purpose of the Study:

  • To provide a comprehensive overview of GBM characteristics influencing therapies.
  • To review current immunotherapeutic strategies for GBM, focusing on phase 3 trials.
  • To explore novel approaches and future directions in GBM immunotherapy.

Main Methods:

  • Literature review of GBM characteristics and immunotherapeutic strategies.
  • Analysis of clinical trial data for immunotherapies in GBM.
  • Synthesis of current research and future prospects in GBM immunotherapy.

Main Results:

  • GBM presents unique challenges for conventional and immune-based therapies.
  • Several immunotherapeutic strategies, including checkpoint inhibitors, T cell therapies, and vaccines, are in clinical evaluation.
  • Phase 3 studies are underway for select immunotherapies, indicating progress.

Conclusions:

  • Developing effective GBM immunotherapy requires understanding its distinct biological features.
  • Current immunotherapeutic strategies show potential but require further optimization.
  • Novel approaches and continued research are essential to improve outcomes for GBM patients.
Keywords:
CAR-T cell therapyDNA/RNA vaccinesGBMGBM immunosuppressive tumor microenvironmentadoptive cell therapyimmune checkpoint therapyimmunotherapyoncolytic virotherapyvaccination therapy

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.9K
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

1.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K